This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its structure, featuring a trifluoromethyl group and a benzylamine moiety, makes it valuable for developing compounds with potential biological activity, particularly in the design of CNS (central nervous system) drugs. It is also explored in the creation of small molecule inhibitors targeting specific enzymes or receptors, contributing to drug discovery efforts for treating neurological disorders, pain management, or inflammatory conditions. Additionally, its unique chemical properties are leveraged in organic synthesis to introduce trifluoromethyl groups into complex molecules, enhancing their stability or bioavailability.